Despite the high incidence of CDKN2A mutations, the number of patients in our cohort was limited, so we did not investigate prognostic features, but instead we focused on the interplay between germline and somatic variants in the key genetic drivers of cutaneous melanoma. This evidence concerns the gene CDKN2A and cutaneous melanoma.